Onal Kalkan, N.; Urakcı, Z.; Mermit Erçek, B.; Bilen, E.; Arvas, H.; Akkuş, M.H.
Clinical Utility of Pan-Immune Inflammation Value (PIV) in Predicting Prognosis of Endometrial Cancer. J. Clin. Med. 2025, 14, 7885.
https://doi.org/10.3390/jcm14217885
AMA Style
Onal Kalkan N, Urakcı Z, Mermit Erçek B, Bilen E, Arvas H, Akkuş MH.
Clinical Utility of Pan-Immune Inflammation Value (PIV) in Predicting Prognosis of Endometrial Cancer. Journal of Clinical Medicine. 2025; 14(21):7885.
https://doi.org/10.3390/jcm14217885
Chicago/Turabian Style
Onal Kalkan, Nurhan, Zuhat Urakcı, Berrak Mermit Erçek, Erkan Bilen, Hayati Arvas, and Mehmet Hadi Akkuş.
2025. "Clinical Utility of Pan-Immune Inflammation Value (PIV) in Predicting Prognosis of Endometrial Cancer" Journal of Clinical Medicine 14, no. 21: 7885.
https://doi.org/10.3390/jcm14217885
APA Style
Onal Kalkan, N., Urakcı, Z., Mermit Erçek, B., Bilen, E., Arvas, H., & Akkuş, M. H.
(2025). Clinical Utility of Pan-Immune Inflammation Value (PIV) in Predicting Prognosis of Endometrial Cancer. Journal of Clinical Medicine, 14(21), 7885.
https://doi.org/10.3390/jcm14217885